Announcement on webinar about: Measuring Patient and Physician Benefit–Risk Preferences in Antipsychotic Clinical Trials

By Eva Katz

Eva Katz

Eva Katz, PhD, MPH, RD

Recently, we shared an example of adopting benefit risk methodology to schizophrenia studies (click here for more information). Now we are happy to announce that Eva Katz, the epidemiologist behind this nice case study, will give a webinar about it and there will be the possibility to have a discussion around this and how other areas can benefit from it.

REGISTER HERE

The 1 hour event takes place on September 26th. 4pm European time, 3pm UK time, 10am Eastern time in the US.

Here is a short bio of Eva:

Eva Katz, PhD, MPH, RD is Associate Director of Benefit-Risk and Epidemiology at Janssen Research & Development.  In this role Dr. Katz serves as an internal consultant for benefit‐risk methodology and patient‐focused benefit‐risk assessment, guiding clinical teams across therapeutic areas in medication benefit-risk assessment using both qualitative and quantitative methods.  As part of the efforts to integrate the patient experience in clinical trials, Dr. Katz has helped integrate patient and physician preference surveys within phase 3 clinical trials. Eva also participates in external task forces on benefit‐risk assessment methods and patient focused drug development. Prior to her role in Benefit-Risk, Dr. Katz was part of the patient reported outcomes team at Janssen where she worked cross‐functionally to develop strategy for development, selection and implementation of Patient‐Reported Outcomes (PROs) in phase 2 and phase 3 clinical trials of pharmaceutical products across therapeutic areas. Dr. Katz received her B.S. in Nutritional Science from Rutgers University, her M.P.H. from the University of California, Berkeley and her doctorate in Nutrition Epidemiology from the Gillings School of Global Public Health, University of North Carolina, Chapel Hill.

Subscribe to our mailing list to be the first one to hear about when the registration opens for similar webinars and to get monthly updates from the website!

 

Please note: I reserve the right to delete comments that are offensive or off-topic.

Leave a reply and share your perspective for others to learn